A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Arena Pharmaceuticals, Inc.
Start Date
January 20, 2021
End Date
July 5, 2023
Administered By
Medicine, Gastroenterology
Awarded By
Arena Pharmaceuticals, Inc.
Start Date
January 20, 2021
End Date
July 5, 2023